On March 25, 2022, Franchise Global Health Inc. (formerly capital pool company Mercury Acquisitions Corp.) ("Franchise Global") (TSXV: FGH, formerly traded as MERC.P) announced that it had completed its previously announced business combination with Franchise Cannabis Corp. ("Franchise"), resulting in a reverse take-over of Franchise Global, which transaction constituted Franchise Global's "Qualifying Transaction" within the meaning of Policy 2.4 - Capital Pool Companies of the TSX Venture Exchange.
Franchise Global, through its subsidiaries, is a multi-national operator in the medical cannabis and pharmaceutical industries, with principal operations in Germany and with operations, assets, strategic partnerships and investments internationally. Franchise Global's business objective is to develop a fully-integrated, leading European medical cannabis business, with the goal of providing high-quality pharmaceutical grade medical cannabis to distribution partners and, ultimately, to patients, at competitive prices.
Gowling WLG advised Franchise with respect to this transaction with a team that included Peter Simeon, Jacob Cawker, Nav Pannu, Sean Walsh and Blair Somerville, and assisted by student-at-law Jevaughn Johnson.